-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-195-uterine-fibroids-final.pdf
December 01, 2017 - Management of Uterine Fibroids - Evidence Summary
Comparative Effectiveness Review
Number 195
Effective Health Care Program
Management of Uterine Fibroids
Evidence Summary
Introduction
Uterine fibroids (i.e., leiomyomata) are
common benign smooth muscle tumors
of the uterus. Most women will develop
one or mor…
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1512.pdf
December 01, 2015 - PEPTIC ULCER #11
AHRQ Healthcare Horizon Scanning System – Potential
High-Impact Interventions Report
Priority Area 11: Peptic Ulcer Disease and Dyspepsia
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
5600 Fishers Lane
Rockville, MD 20857
…
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1406.pdf
June 01, 2014 - Arthritis and Nontraumatic Joint Disease
AHRQ Healthcare Horizon Scanning System – Potential
High-Impact Interventions Report
Priority Area 01: Arthritis and Nontraumatic Joint
Disease
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither…
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1312.pdf
December 01, 2013 - PULMONARY with "Discussions" in Exec Summary
AHRQ Healthcare Horizon Scanning System – Potential
High-Impact Interventions Report
Priority Area 13: Pulmonary Disease, Including Asthma
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither…
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1512.pdf
December 01, 2015 - #05 DEPRESSION
AHRQ Healthcare Horizon Scanning System – Potential
High-Impact Interventions Report
Priority Area 05: Depression and Other Mental Health
Disorders
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
5600 Fishers Lane
Rockville, M…
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1506.pdf
June 01, 2015 - Arthritis and Nontraumatic Joint Disease
AHRQ Healthcare Horizon Scanning System – Potential
High-Impact Interventions Report
Priority Area 01: Arthritis and Nontraumatic Joint
Disease
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_disposition-comments.pdf
June 07, 2013 - statement about not knowing
how long it takes for a cancer to spread from the ovary to
an advanced stage
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-health-children_disposition-comments.pdf
December 19, 2016 - Disposition of Comments for CER 181 Mental Health Care
Source: https://www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/
?pageaction=displayproduct&productid=2372
Published Online: December 19, 2016
Comparative Effectiveness Review Disposition of Comments Report
Research Revie…
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-women-in-the-postpartum-period-what-is-the-effectiveness-and-safety-of-screening-and-treatment-for-depression-please-use-the-uspstf-framework-which-considers-not-only-screening-but-followup-treatment-and-management-the-tr
October 01, 2011 - (For example, an ethnic group, stage or severity of a disease.)
-
effectivehealthcare.ahrq.gov/decision-aids/lung-cancer-screening/static/lung-cancer-screening-clin-summary.pdf
March 01, 2016 - detection
and treatment is ideal, only 15 percent of
lung cancer cases are diagnosed at an early
stage
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/measurement-and-outcomes-need-consensus-definitions-state-medicaid-programs-need-robust-hedis-and-ncqa-measures-for-all-severe-and-persistent-mental-health-conditions-consensus-definitions-would-help-answer-questions-such-as-
November 23, 2010 - (For example, an ethnic group, stage or severity of a disease.)
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/lung-cancer-screening-clin-summary.pdf
March 01, 2016 - detection
and treatment is ideal, only 15 percent of
lung cancer cases are diagnosed at an early
stage
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/the-american-college-of-chest-physicians-accp-proposes-to-update-the-following-4-guideline-topics-from-the-2006-publication-on-the-diagnosis-and-management-of-cough-accp-evidence-based-clinical-practice-guidelines1-1-assessin
January 01, 2006 - (For example, an ethnic group, stage or severity of a disease.)
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-imaging_disposition-comments.pdf
October 01, 2014 - It is refreshing to
see concerns of patient anxiety and quality of life sharing the stage
with the … That is, changes in therapeutic management or stage
reclassification are appropriate terminal points
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-observational-studies_methods.pdf
June 01, 2010 - consultation with clinical experts may also identify
important gaps in the RCT evidence at the protocol stage … registry in the United States that enrolls
patients who have received ventricular assist devices for end-stage … Well-known or large RCTs should be examined in detail at this stage.
-
effectivehealthcare.ahrq.gov/sites/default/files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
May 01, 2012 - Effectiveness was evident in
low-risk disease (PSA <10
ng/ml, stage ²T2a tumors, or
Gleason ²6) and … Hoskin, 201219 -- n = 218
EBRT: n = 108
EBRT + high-
dose-rate
brachytherapy
boost: n = 110
Stage … Effectiveness
was evident in low-risk disease (PSA <10
ng/ml, stage ²T2a tumors, or Gleason ²6)
and
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
May 01, 2012 - Effectiveness was evident in
low-risk disease (PSA <10
ng/ml, stage ²T2a tumors, or
Gleason ²6) and … Hoskin, 201219 -- n = 218
EBRT: n = 108
EBRT + high-
dose-rate
brachytherapy
boost: n = 110
Stage … Effectiveness
was evident in low-risk disease (PSA <10
ng/ml, stage ²T2a tumors, or Gleason ²6)
and
-
effectivehealthcare.ahrq.gov/products/ace-inhibitor-arb-update/research-protocol
May 07, 2010 - failure, cerebral vascular disease or events [including stroke], symptomatic coronary artery disease, end-stage … the current search strategy and initial number of abstracts to be included in our abstract screening stage
-
effectivehealthcare.ahrq.gov/products/cancer-quality-indicator-testing/research
May 19, 2010 - the cancer registry to identify patients diagnosed in 2006 with one of the following tumor types and stage … At JHH/SKCCC, the cancer registry identified patients with stage IV lung, pancreatic, breast, and colorectal … cancer (and Stage IIIB for lung cancer) disease in 2003-2005 who died 2-15 months after diagnosis.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_research-protocol.pdf
November 03, 2014 - Therefore primary care physicians (PCPs) and emergency physicians are
well-positioned to diagnose early-stage … Full-text articles will be dually reviewed;
disagreements regarding inclusion at the full-text stage … comorbidities, we will determine whether studies report factors such as sex, duration of
the condition, and stage